Lab-grown blood vessel for heart bypass surgery
Part of Heart & circulation clinical trials.
This trial tests a lab-grown blood vessel that is designed to be used as an extra bypass graft during heart surgery. It aims to offer a safe alternative for patients who need multiple bypasses, and the new vessel may help improve long-term blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for your first bypass surgery (CABG) to treat blocked heart arteries.
- At least one of your heart arteries must be severely narrowed or blocked (by 80% or more), and your doctor must confirm it is suitable.
- You have not had a heart attack in the past week, and your heart is pumping normally or near normally.
- You do not have significant bleeding, clotting, or immune system problems, and your kidneys and liver are in good condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This trial tests whether transplanting tiny heart “micrografts” from the left heart chamber area can improve heart function after cardiac surgery. It is meant for people with weakened heart pumping and heart failure symptoms despite medicine.
This study compares two surgical techniques for heart bypass: using the left internal thoracic artery in one specific way versus another. It may help improve how well the bypass works in people who need bypass surgery for multiple blocked heart arteries.
This study tests a new device (the VentriCure) that temporarily helps your heart pump during a stent procedure. It is for people with heart failure and blocked arteries who are at high risk for bypass surgery.
This trial tests whether a blood-thinner drug called cangrelor helps patients who are having a special type of bypass surgery that uses a small incision instead of opening the whole chest. The surgery connects a healthy artery from your chest wall directly to a blocked heart vessel to restore blood flow.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.